Summary of project PR002693

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002693. The data can be accessed directly via it's Project DOI: 10.21228/M8JR8G This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR002693
Project DOI:doi: 10.21228/M8JR8G
Project Title:UNTARGETED METABOLOMIC AND LIPIDOMIC PROFILING IN CYSTIC FIBROSIS PATIENTS USING UPLC-QTOF-MS
Project Type:Untargeted analysis
Project Summary:Cystic fibrosis (CF), also known as mucoviscidosis, is a rare autosomal recessive genetic disease. It is caused by a mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, which disrupts the normal function of the chloride ion channel. Clinical manifestations of CF typically include recurrent respiratory infections, chronic airway inflammation, progressive decline in lung function, and intermittent pulmonary exacerbations. The primary aim of our study is to identify plasma biomarkers in patients with cystic fibrosis through untargeted metabolomic and lipidomic analyses, with the goal of enabling early detection, accurate diagnosis, and effective monitoring of the disease.
Institute:Université de Sherbrooke
Department:PEDIATRICS/ Genetics service
Laboratory:Centre d’expertise en spectrométrie de masse clinique Waters-CHUS
Last Name:FARJALLAH
First Name:ASMA
Address:3001, 12e Avenue Nord, Sherbrooke, Québec, Canada
Email:asma.farjallah@usherbrooke.ca
Phone:8193452671

Summary of all studies in project PR002693

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)		 Release
Date		VersionSamplesDownload
(* : Contains raw data)
ST004266 UNTARGETED METABOLOMIC AND LIPIDOMIC PROFILING IN CYSTIC FIBROSIS PATIENTS USING UPLC-QTOF-MS Homo sapiens Université de Sherbrooke MS* 2025-10-10 1 180 Uploaded data (4G)*
  logo